Life Science Network
@lifescience
Followers
3K
Following
1K
Media
3K
Statuses
9K
Powered by CG Life, the Life Science Network (LSN) is a relaxed community of life science professionals, researchers, communicators, marketers and advocates.
Joined June 2012
A fabulous, complimentary life science networking reception is coming up during Advances in Single Cell & Spatial Biology on 9/14. CG Life is co-hosting. It should make for an excellent evening of drinks, bites, and science!
0
0
0
Roche buys U.S. rights to Roivant bowel disease drug in $7.1 billion deal
0
0
0
New Cancer Therapy Target Stops Tumor Cells From Sharing Resources
0
0
0
Seed-stage Bay Area biotechs kick off return of BIO Investor Forum - San Francisco Business Times via @SFBusinessTimes
0
0
0
Carl Icahn sues Illumina board members over Grail acquisition -
0
0
0
Aldeyra braces for potential dry eye disease rejection after FDA says more data are necessary -
0
0
0
These Japanese life science firms came to San Diego to study startups
0
1
1
Better Therapeutics begins rolling out digital app for Type 2 diabetes
0
0
0
Pfizer Expands in Immunology With FDA Approval of New Ulcerative Colitis Drug
0
0
0
Thermo Fisher Scientific to buy Olink in $3.1 billion deal
reuters.com
Thermo Fisher Scientific would acquire Olink Holding AB in a deal valued at $3.1 billion, the companies said on Tuesday, as the U.S. medical equipment maker seeks to boost its life sciences portfolio...
0
0
0
Sanofi adds another AI alliance, this time for biologics with Baidu CEO’s startup -
0
0
0
RT @gwendolynawu: A decade later, biotech’s CRISPR revolution is still going strong. I traced the history of gene editing startups and what….
biopharmadive.com
Once the specialty of a few select drugmakers, CRISPR gene editing is now an essential technology for a growing group of biotechs, many led by former students of the field's pioneering scientists.
0
2
0
Twist Bioscience, Bayer Enter Antibody Discovery Deal Valued at up to $188 Million via @clinicalomics
0
0
0
RT @cglifeagency: Researchers are using CRISPR for more complex diseases such as Alzheimer's. Studies done at @UCSanDiego, @DukeU, and more….
statnews.com
Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alzheimer's.
0
1
0
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone $ETON via $ETON
0
0
0
Gilead stops another CD47 study, this time in acute myeloid leukemia -
0
0
0